Anti-TB efficacy of PBTZ169 in mice with different genetic susceptibility to infection
B. Nikonenko (Moscow, Russian Federation), V. Makarov (Moscow, Russian Federation), I. Bocharova (Moscow, Russian Federation), M. Korotetskaya (Moscow, Russian Federation), E. Kondratieva (Moscow, Russian Federation), N. Sterzhanova (Moscow, Russian Federation), A. Apt (Moscow, Russian Federation)
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Nikonenko (Moscow, Russian Federation), V. Makarov (Moscow, Russian Federation), I. Bocharova (Moscow, Russian Federation), M. Korotetskaya (Moscow, Russian Federation), E. Kondratieva (Moscow, Russian Federation), N. Sterzhanova (Moscow, Russian Federation), A. Apt (Moscow, Russian Federation). Anti-TB efficacy of PBTZ169 in mice with different genetic susceptibility to infection. 2805
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: